Buscar
Mostrando ítems 1-10 de 4021
Vaccination-induced skin-resident memory CD8(+) T cells mediate strong protection against cutaneous melanoma
(Taylor & Francis, 2018)
Memory CD8(+) T cell responses have the potential to mediate long-lasting protection against cancers. Resident memory CD8(+) T (Trm) cells stably reside in non-lymphoid tissues and mediate superior innate and adaptive ...
Editorial: Epitope discovery and Synthetic Vaccine design
(Frontiers Media Sa, 2018)
Natural killer cells as helper cells in dendritic cell cancer vaccines
(Frontiers Research Foundation, 2015-01)
Vaccine-based cancer immunotherapy has generated highly variable clinical results due to differing methods of vaccine preparation and variation in patient populations among other lesser factors. Moreover, these clinical ...
ACELLULAR AND "LOW" PERTUSSIS VACCINES: ADVERSE EVENTS AND THE ROLE OF MUTATIONS
(Inst Medicina Tropical Sao PauloSao PauloBrasil, 2009)
Editorial: Toward a Melanoma Dendritic Cell Vaccine using Neoantigens
(International Journal of Clinical Dermatology & Research (IJCDR), 2017)
Rare detection of bordetella pertussis pertactin-deficient strains in Argentina
(Centers Disease Control, 2019-11)
Pertussis resurgence had been attributed to waning vaccine immunity and Bordetella pertussis adaptation to escape vaccine-induced immunity. Circulating bacteria differ genotypically from strains used in production of ...
Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia
(ELSEVIER SCI LTD, 2010)
The immunogenicity and tolerability of virosome and of split influenza vaccines in patients with sickle cell anemia (SS) were evaluated Ninety SS patients from 8 to 34 years old were randomly assigned to receive either ...
Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia
(Elsevier B.V., 2010-01-22)
The immunogenicity and tolerability of virosome and of split influenza vaccines in patients with sickle cell anemia (SS) were evaluated Ninety SS patients from 8 to 34 years old were randomly assigned to receive either ...
Dendritic cell-based vaccine efficacy: Aiming for hot spots
(Frontiers Research Foundation, 2015-03)
Many approaches for cancer immunotherapy have targeted dendritic cells (DCs), directly or indirectly, for the induction of antitumor immune responses. DC-based vaccines have been developed using a wide variety of ex vivo ...
Recent advances in DNA vaccines for autoimmune diseases
(Expert Reviews, 2009-02-01)
Vaccination is one of the most powerful health tools available owing to its ability to confer protection against various diseases. The long-term impact of such protection in terms of public-health savings is nearly ...